Cargando…

Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer

BACKGROUND: Hypofractionated whole-breast irradiation is a standard adjuvant therapy for early-stage breast cancer. This study evaluates the plan quality and efficacy of an in-house-developed automated radiotherapy treatment planning algorithm for hypofractionated whole-breast radiotherapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ting-Chun, Lin, Chih-Yuan, Li, Kai-Chiun, Ji, Jin-Huei, Liang, Ji-An, Shiau, An-Cheng, Liu, Liang-Chih, Wang, Ti-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077022/
https://www.ncbi.nlm.nih.gov/pubmed/32178694
http://dx.doi.org/10.1186/s13014-020-1468-9
_version_ 1783507343903817728
author Lin, Ting-Chun
Lin, Chih-Yuan
Li, Kai-Chiun
Ji, Jin-Huei
Liang, Ji-An
Shiau, An-Cheng
Liu, Liang-Chih
Wang, Ti-Hao
author_facet Lin, Ting-Chun
Lin, Chih-Yuan
Li, Kai-Chiun
Ji, Jin-Huei
Liang, Ji-An
Shiau, An-Cheng
Liu, Liang-Chih
Wang, Ti-Hao
author_sort Lin, Ting-Chun
collection PubMed
description BACKGROUND: Hypofractionated whole-breast irradiation is a standard adjuvant therapy for early-stage breast cancer. This study evaluates the plan quality and efficacy of an in-house-developed automated radiotherapy treatment planning algorithm for hypofractionated whole-breast radiotherapy. METHODS: A cohort of 99 node-negative left-sided breast cancer patients completed hypofractionated whole-breast irradiation with six-field IMRT for 42.56 Gy in 16 daily fractions from year 2016 to 2018 at a tertiary center were re-planned with an in-house-developed algorithm. The automated plan-generating C#-based program is developed in a Varian ESAPI research mode. The dose-volume histogram (DVH) and other dosimetric parameters of the automated and manual plans were directly compared. RESULTS: The average time for generating an autoplan was 5 to 6 min, while the manual planning time ranged from 1 to 1.5 h. There was only a small difference in both the gantry angles and the collimator angles between the autoplans and the manual plans (ranging from 2.2 to 5.3 degrees). Autoplans and manual plans performed similarly well in hotspot volume and PTV coverage, with the autoplans performing slightly better in the ipsilateral-lung-sparing dose parameters but were inferior in contralateral-breast-sparing. The autoplan dosimetric quality did not vary with different breast sizes, but for manual plans, there was worse ipsilateral-lung-sparing (V(4Gy)) in larger or medium-sized breasts than in smaller breasts. Autoplans were generally superior than manual plans in CI (1.24 ± 0.06 vs. 1.30 ± 0.09, p < 0.01) and MU (1010 ± 46 vs. 1205 ± 187, p < 0.01). CONCLUSIONS: Our study presents a well-designed standardized fully automated planning algorithm for optimized whole-breast radiotherapy treatment plan generation. A large cohort of 99 patients were re-planned and retrospectively analyzed. The automated plans demonstrated similar or even better dosimetric quality and efficacy in comparison with the manual plans. Our result suggested that the autoplanning algorithm has great clinical applicability potential.
format Online
Article
Text
id pubmed-7077022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70770222020-03-18 Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer Lin, Ting-Chun Lin, Chih-Yuan Li, Kai-Chiun Ji, Jin-Huei Liang, Ji-An Shiau, An-Cheng Liu, Liang-Chih Wang, Ti-Hao Radiat Oncol Research BACKGROUND: Hypofractionated whole-breast irradiation is a standard adjuvant therapy for early-stage breast cancer. This study evaluates the plan quality and efficacy of an in-house-developed automated radiotherapy treatment planning algorithm for hypofractionated whole-breast radiotherapy. METHODS: A cohort of 99 node-negative left-sided breast cancer patients completed hypofractionated whole-breast irradiation with six-field IMRT for 42.56 Gy in 16 daily fractions from year 2016 to 2018 at a tertiary center were re-planned with an in-house-developed algorithm. The automated plan-generating C#-based program is developed in a Varian ESAPI research mode. The dose-volume histogram (DVH) and other dosimetric parameters of the automated and manual plans were directly compared. RESULTS: The average time for generating an autoplan was 5 to 6 min, while the manual planning time ranged from 1 to 1.5 h. There was only a small difference in both the gantry angles and the collimator angles between the autoplans and the manual plans (ranging from 2.2 to 5.3 degrees). Autoplans and manual plans performed similarly well in hotspot volume and PTV coverage, with the autoplans performing slightly better in the ipsilateral-lung-sparing dose parameters but were inferior in contralateral-breast-sparing. The autoplan dosimetric quality did not vary with different breast sizes, but for manual plans, there was worse ipsilateral-lung-sparing (V(4Gy)) in larger or medium-sized breasts than in smaller breasts. Autoplans were generally superior than manual plans in CI (1.24 ± 0.06 vs. 1.30 ± 0.09, p < 0.01) and MU (1010 ± 46 vs. 1205 ± 187, p < 0.01). CONCLUSIONS: Our study presents a well-designed standardized fully automated planning algorithm for optimized whole-breast radiotherapy treatment plan generation. A large cohort of 99 patients were re-planned and retrospectively analyzed. The automated plans demonstrated similar or even better dosimetric quality and efficacy in comparison with the manual plans. Our result suggested that the autoplanning algorithm has great clinical applicability potential. BioMed Central 2020-03-17 /pmc/articles/PMC7077022/ /pubmed/32178694 http://dx.doi.org/10.1186/s13014-020-1468-9 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lin, Ting-Chun
Lin, Chih-Yuan
Li, Kai-Chiun
Ji, Jin-Huei
Liang, Ji-An
Shiau, An-Cheng
Liu, Liang-Chih
Wang, Ti-Hao
Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
title Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
title_full Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
title_fullStr Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
title_full_unstemmed Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
title_short Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
title_sort automated hypofractionated imrt treatment planning for early-stage breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077022/
https://www.ncbi.nlm.nih.gov/pubmed/32178694
http://dx.doi.org/10.1186/s13014-020-1468-9
work_keys_str_mv AT lintingchun automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT linchihyuan automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT likaichiun automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT jijinhuei automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT liangjian automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT shiauancheng automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT liuliangchih automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer
AT wangtihao automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer